Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03030313 · ClinicalTrials.gov registry record · NA

Respiration Rate Monitoring in COPD Patients

A NA study, sponsored by ResMed.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03030313: Completed NA study, sponsored by ResMed.

NCT03030313 is a NA study that has completed, run by ResMed. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03030313, a NA study, has completed, sponsored by ResMed.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.

Primary Outcome

Indicators of healthcare utilization include change in medications for COPD, number of office or ER visits, number of hospitalizations.

Interventions

  • DEVICE Reassure Non-Contact Respiration Monitor

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-12-01
Est. Completion 2017-07-26
Phase NA
ResMed

25 total trials

What the finished NCT03030313 record still lists

NCT03030313 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Reassure Non-Contact Respiration Monitor is the first listed.

NCT03030313 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03030313 about?

NCT03030313 is a clinical study titled "Respiration Rate Monitoring in COPD Patients". Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.

What is the current status of trial NCT03030313?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-12-01. Estimated completion is 2017-07-26.

What interventions are being tested in trial NCT03030313?

The interventions under investigation include: Reassure Non-Contact Respiration Monitor (DEVICE).

Who is sponsoring clinical trial NCT03030313?

This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03030313's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03030313, the US trial registry maintained by the National Library of Medicine. NCT03030313 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.